Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
KVUE
HoldPremium GrowerKenvue Inc. · Consumer Defensive · United States · $36.8B · Avg Vol: $401M/d
COMPANY DESCRIPTION
Kenvue Inc. is a pure-play consumer health company, spun off from Johnson & Johnson, that boasts an unparalleled portfolio of iconic, market-leading brands across Self Care, Skin Health & Beauty, and Essential Health segments, including Tylenol, Band-Aid, and Neutrogena. The company's formidable competitive moat stems from deep consumer trust, global brand recognition, extensive R&D capabilities, and a vast distribution network inherited from its former parent. This collection of household names ensures resilient demand in the defensive consumer health sector.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.9B | 15.4B | 15.5B | 15.1B | 0.4% | 15.4B | 15.6B | 16.0B | 2.7% |
| EPS | 1.09 | 0.90 | 0.54 | 0.77 | -11.0% | 0.85 | 0.84 | 0.88 | 7.1% |
| Shares | 1.9B | 1.9B | 1.9B | 1.9B | +1.4% | 1.9B | — | — | — |
| Debt | 116.0M | 8.4B | 8.7B | 8.7B | 321.3% | 8.6B | — | — | — |
| Equity | 20.0B | 11.2B | 9.7B | 10.8B | -18.6% | — | — | — | — |
| Op CF | 2.5B | 3.2B | 1.8B | 2.2B | -4.5% | 2.3B | — | — | — |
| Inv CF | -390.0M | -488.0M | -425.0M | -436.0M | — | — | — | — | — |
| Fin CF | -1.6B | -2.5B | -1.6B | -1.8B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of KVUE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| KVUE | Kenvue Inc.(you) | $36.8B | 58 | Hold |
| KMB | Kimberly-Clark Corporation | $36.4B | 52 | Hold |
| CL | Colgate-Palmolive Company | $72.3B | 58 | Hold |
| CHD | Church & Dwight Co., Inc. | $24.0B | 47 | Hold |
| EL | The Estée Lauder Companies Inc. | $37.4B | 33 | Sell |
| CLX | The Clorox Company | $12.4B | 38 | Hold |
| PG | The Procter & Gamble Company | $334.2B | 48 | Hold |
| IPAR | Interparfums, Inc. | $3.8B | 69 | Buy |
| ELF | e.l.f. Beauty, Inc. | $6.1B | 30 | Sell |
| NWL | Newell Brands Inc. | $2.6B | 74 | Buy |
Peer medians: ROE 9.2% · P/E 19.9x · Gross margin 34.5%